SPRO

Q: What is the price of Spero Therapeutics (SPRO) today?

The price of Spero Therapeutics (SPRO) today is $ 2.43, with return of 317.53% compared to the last year. The price of Spero Therapeutics (SPRO) started the year trading around $ 2.33 and today it is at $ 2.43. Follow the real-time price chart, the historical price of Spero Therapeutics (SPRO) and international markets.

Q: When does Spero Therapeutics (SPRO) pay dividends?

Spero Therapeutics (SPRO) did not distribute dividends in the last year.

Q: Is Spero Therapeutics (SPRO) worth it?

Currently, Spero Therapeutics (SPRO) is priced at $ 2.43, with a P/E of 15.88%, representing a deviation of 462% from its historical average P/E. In the last year, the stock showed a variation of 317.53 in its price and distributed $ 0.00 in dividends, resulting in a Dividend Yield of 0.00%. The total shareholder return was 317.53%.It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Q: How can I buy Spero Therapeutics (SPRO) stock?

Investing in stocks of Spero Therapeutics (SPRO) can be done in two ways: by buying the stock abroad. The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

Q: How much would 100 shares of Spero Therapeutics (SPRO) yield today?

The yield of Spero Therapeutics (SPRO) was 6.11% in the last month, 317.53% in the last year and -81.81% in the last 5 years (already considering appreciation and dividends).In the last 12 months, the company paid a total of $ 0.00 in dividends, with a Dividend Yield of 0.00%.If you wanted to buy 100 stocks of Spero Therapeutics (SPRO) today, the total investment would be $ 243.00, based on the current price of $ 2.43.If past performance were to repeat, the return on your investment would be:In 1 year: $ 1,014.60In 5 years: $ 44.20In 10 years: $ 243.00It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Spero Therapeutics Inc.

Price

$ 2.43

return (12m)

317.53%

p/e

15.88

p/bv

2.31

DIVIDEND YIELD

0.00%

SPRO price

SPRO

If you had invested

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

ago, you would now have *

ago, you would now have:

*The figure considers the reinvestment of dividends.

Return on Investment SPRO

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

6.11%

3 months

3.40%

1 year

317.53%

2 years

43.79%

5 years

-81.81%

10 years

0.00%

Fundamentals SPRO

review the fundamentals of Spero Therapeutics shares

P/E

15.88

Sector: -5.82 Industry: -5.82

P/S (PSR)

2.28

Sector: -4.74 Industry: -4.74

P/BV

2.31

Sector: 1.40 Industry: 1.40

DIVIDEND YIELD (DY)

0.00%

Sector: - Industry: -

ROA

12.43%

Sector: -72.38% Industry: -72.38%

ROE

14.52%

Sector: -84.15% Industry: -84.15%

ROIC

885.83%

Sector: -1,194.38% Industry: -1,194.38%

NET MARGIN

14.37%

Sector: -46.16% Industry: -46.16%

GROSS MARGIN

100.00%

Sector: 35.92% Industry: 35.92%

OPERATING MARGIN

12.01%

Sector: -46.05% Industry: -46.05%

EV/EBITDA

19.01

Sector: -5.52 Industry: -5.52

EV/EBIT

19.01

Sector: -5.77 Industry: -5.77

PRICE-TO-ASSETS

1.97

Sector: 1.13 Industry: 1.13

BVPS

1.05

Sector: 1.63 Industry: 1.63

EPS

0.15

Sector: -2.73 Industry: -2.73

EQUITY-TO-ASSETS RATIO

0.86

Sector: 0.32 Industry: 0.32

LIABILITIES / ASSETS

0.14

Sector: 0.33 Industry: 0.33

CAGR REVENUE 5 YEARS

26.71%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

0.00%

Sector: - Industry: -

FAIR VALUE OF Spero Therapeutics ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$ 2.43

Fair Value

$ 0.00

Upside/Downside Return potential.

-22.53%

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Fundamentals SPRO

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
JNJ	21.84	7.39	33.81%	2.14%	$ 585.48 B	28.46%
PFE	20.72	1.73	8.35%	6.07%	$ 161.03 B	12.42%
ABBV	87.32	0.00	0.00%	3.18%	$ 369.02 B	6.91%
NVO	10.48	5.40	51.50%	4.56%	$ 164.23 B	33.05%
MRK	16.43	0.00	0.00%	2.71%	$ 300.00 B	28.08%
AZN	30.87	6.48	20.99%	1.57%	$ 315.61 B	17.41%
GILD	20.39	7.67	37.62%	2.28%	$ 173.52 B	28.90%
BMY	17.20	-3.56	-20.72%	4.18%	$ 121.35 B	14.64%
ZTS	19.33	15.51	80.25%	1.72%	$ 51.66 B	28.23%
REGN	17.42	2.51	14.41%	0.47%	$ 78.47 B	31.41%
HALO	24.01	155.91	649.21%	0.00%	$ 7.61 B	22.69%
AMGN	24.32	21.66	89.06%	2.78%	$ 187.54 B	20.98%
MCK	25.06	-1,098.65	-4,383.84%	0.36%	$ 108.77 B	1.09%
VRTX	28.19	5.97	21.18%	0.00%	$ 111.43 B	32.94%
CAH	30.39	-18.71	-61.56%	0.95%	$ 50.52 B	0.68%
ADMA	14.89	4.58	30.78%	0.00%	$ 2.19 B	28.80%
BIIB	20.16	1.43	7.08%	0.00%	$ 26.07 B	13.07%
HRMY	9.96	1.82	18.24%	0.00%	$ 1.58 B	18.27%

Stock vs Indice Comparison Tool

If you had invested (change) 2 years years ago, ago, you would now have

R$ 1.000,00 in PETR4 You would now have R$ 2.294,60

R$ 1.000,00 in LEVE3 You would now have R$ 5.240,60

*The value considers the reinvestment of dividends.

SPRO Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Spero Therapeutics

Spero Therapeutics Inc.

Average Investor10 user rating

4.0 (0 people)

United States

13 years

Founded: 2013

2017

Time since IPO - 9 years

89

Employees

The Company Spero Therapeutics Inc. (United States), is listed on Nasdaq with a market value of $ 136.08 Millions, having an equity of $ 59.02 Millions.

With a total of 89 employees, the company is listed in the sector of Health Care and categorized in industry of Biotechnology.

In the last 12 months the Company had a revenue of $ 59.62 Millions, which generated a profit in the amount of $ 8.57 Millions.

As for its main indicators, the Company has a P/E ratio of 15.88, a P/BV ratio of 2.31 and in the last 12 months the Company did not pay dividends.

The Company is traded internationally through the ticker SPRO.

Market cap

$ 136.08 Millions

Net worth

$ 59.02 Millions

US$ 59,020,000.00

Assets

$ 68.92 Millions

US$ 68,920,000.00

Total Shares Outstanding

56.00 Millions

56,000,000

Average Daily Trading Volume

$ 328.11 Thousand

US$ 328,111.98

Sector

Health Care

Industry

Biotechnology

SPRO

SPRO revenue and profits

Financial Results SPRO

DRAG THE FRAME TO SEE MORE DATA

SPRO cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

BFRA - Biofrontera

$ - -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$ 884.28 29,96% (12M)

P/E

25.06

0.36%

ROE

-4,383.84%

P/BV

-1,098.65

CAH - Cardinal Health

$ 214.05 67,60% (12M)

P/E

30.39

0.95%

ROE

-61.56%

P/BV

-18.71

JNJ - Johnson & Johnson

$ 243.04 63,02% (12M)

P/E

21.84

2.14%

ROE

33.81%

P/BV

7.39

PFE - Pfizer

$ 28.32 32,24% (12M)

P/E

20.72

6.07%

ROE

8.35%

P/BV

1.73

ABBV - AbbVie

$ 208.84 16,32% (12M)

P/E

87.32

3.18%

ROE

0.00%

P/BV

0.00

MRK - Merck & Co.

$ 120.87 55,08% (12M)

P/E

16.43

2.71%

ROE

0.00%

P/BV

0.00

AZN - AstraZeneca

$ 203.49 57,42% (12M)

P/E

30.87

1.57%

ROE

20.99%

P/BV

6.48

BFRA - Biofrontera

$ - -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$ 884.28 29,96% (12 M)

P/L

25.06

0.36%

ROE

-4,383.84%

P/VP

-1,098.65

CAH - Cardinal Health

$ 214.05 67,60% (12 M)

P/L

30.39

0.95%

ROE

-61.56%

P/VP

-18.71

JNJ - Johnson & Johnson

$ 243.04 63,02% (12 M)

P/L

21.84

2.14%

ROE

33.81%

P/VP

7.39

PFE - Pfizer

$ 28.32 32,24% (12 M)

P/L

20.72

6.07%

ROE

8.35%

P/VP

1.73

ABBV - AbbVie

$ 208.84 16,32% (12 M)

P/L

87.32

3.18%

ROE

0.00%

P/VP

0.00

MRK - Merck & Co.

$ 120.87 55,08% (12 M)

P/L

16.43

2.71%

ROE

0.00%

P/VP

0.00

AZN - AstraZeneca

$ 203.49 57,42% (12 M)

P/L

30.87

1.57%

ROE

20.99%

P/VP

6.48

Frequently Asked Questions

What is the price of Spero Therapeutics (SPRO) today?

The price of Spero Therapeutics (SPRO) today is $ 2.43, with return of 317.53% compared to the last year. The price of Spero Therapeutics (SPRO) started the year trading around $ 2.33 and today it is at $ 2.43. Follow the real-time price chart, the historical price of Spero Therapeutics (SPRO) and international markets.

When does Spero Therapeutics (SPRO) pay dividends?

Spero Therapeutics (SPRO) did not distribute dividends in the last year.

Is Spero Therapeutics (SPRO) worth it?

Currently, Spero Therapeutics (SPRO) is priced at $ 2.43, with a P/E of 15.88%, representing a deviation of 462% from its historical average P/E. In the last year, the stock showed a variation of 317.53 in its price and distributed $ 0.00 in dividends, resulting in a Dividend Yield of 0.00%. The total shareholder return was 317.53%.

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

How can I buy Spero Therapeutics (SPRO) stock?

Investing in stocks of Spero Therapeutics (SPRO) can be done in two ways: by buying the stock abroad. The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.

BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

How much would 100 shares of Spero Therapeutics (SPRO) yield today?

The yield of Spero Therapeutics (SPRO) was 6.11% in the last month, 317.53% in the last year and -81.81% in the last 5 years (already considering appreciation and dividends).

In the last 12 months, the company paid a total of $ 0.00 in dividends, with a Dividend Yield of 0.00%.

If you wanted to buy 100 stocks of Spero Therapeutics (SPRO) today, the total investment would be $ 243.00, based on the current price of $ 2.43.

If past performance were to repeat, the return on your investment would be:

In 1 year: $ 1,014.60
In 5 years: $ 44.20
In 10 years: $ 243.00

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

SPRO

Spero Therapeutics Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment SPRO

review the fundamentals of Spero Therapeutics shares

P/E

P/S (PSR)

P/BV

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

NET MARGIN

GROSS MARGIN

OPERATING MARGIN

EV/EBITDA

EV/EBIT

PRICE-TO-ASSETS

BVPS

EPS

EQUITY-TO-ASSETS RATIO

LIABILITIES / ASSETS

CAGR REVENUE 5 YEARS

CAGR PROFIT 5 YEARS

Graham's Fair Value

If you had invested (change) 2 years years ago, ago, you would now have

current DY: 0.00%

5-year average DY: 0.00%

ABOUT Spero Therapeutics

Spero Therapeutics Inc.

United States

13 years

2017

89

PROFIT X PRICE SPRO

Financial Results SPRO

SPRO cash flow

Asset, Revenue and Profit Growth - SPRO

SPRO balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

PFE - Pfizer

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

PFE - Pfizer

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

Frequently Asked Questions